Critique of Apixaban Versus Warfarin in Patients With Atrial Fibrillation

被引：2
|
作者：
Nedeltchev, Krassen [1 ,2 ]
机构：
[1] Triemli Hosp, Dept Neurol, CH-8063 Zurich, Switzerland
[2] Univ Bern, Bern, Switzerland
来源：
STROKE | 2012年 / 43卷 / 03期
关键词：
anticoagulation; apixaban; atrial fibrillation; DABIGATRAN;
D O I：
10.1161/STROKEAHA.111.640961
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：922 / 923
页数：2
相关论文
共 50 条
  • [31] NON PHARMACOLOGICAL COMPARISON OF APIXABAN VERSUS WARFARIN IN THE TREATMENT OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Vargas Zea, N.
    Prieto Martinez, V
    Garrido Lecca, S.
    VALUE IN HEALTH, 2014, 17 (03) : A113 - A113
  • [32] Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective
    Kostas Athanasakis
    Nadia Boubouchairopoulou
    Eleftheria Karampli
    Filippos Tarantilis
    Paraskevi Savvari
    Aikaterini Bilitou
    John Kyriopoulos
    American Journal of Cardiovascular Drugs, 2017, 17 : 123 - 133
  • [33] Edoxaban versus Warfarin in Patients with Atrial Fibrillation
    Giugliano, Robert P.
    Ruff, Christian T.
    Braunwald, Eugene
    Murphy, Sabina A.
    Wiviott, Stephen D.
    Halperin, Jonathan L.
    Waldo, Albert L.
    Ezekowitz, Michael D.
    Weitz, Jeffrey I.
    Spinar, Jindrich
    Ruzyllo, Witold
    Ruda, Mikhail
    Koretsune, Yukihiro
    Betcher, Joshua
    Shi, Minggao
    Grip, Laura T.
    Patel, Shirali P.
    Patel, Indravadan
    Hanyok, James J.
    Mercuri, Michele
    Vogelmann, O.
    Gonzalez, C.
    Ahuad Guerrero, R.
    Rodriguez, M.
    Albisu, J.
    Rosales, E.
    Allall, O.
    Reguero, M.
    Alvarez, C.
    Garcia, M.
    Ameriso, S.
    Ameriso, P.
    Amuchastegui, M.
    Caceres, M.
    Beloscar, J.
    Petrucci, J.
    Berli, M.
    Budassi, N.
    Valle, M.
    Bustamante Labarta, G.
    Saravia, M.
    Caccavo, A.
    Fracaro, V.
    Cartasegna, L.
    Novas, V.
    Caruso, O.
    Saa Zarandon, R.
    Colombo, H.
    Morandini, M.
    Cuello, J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (22): : 2093 - 2104
  • [34] Dabigatran versus Warfarin in Patients with Atrial Fibrillation
    Worthington, John M.
    Gattellari, Melina
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (27): : 2672 - 2673
  • [35] COST-EFFECTIVENESS OF APIXABAN VERSUS WARFARIN IN CHINESE PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Chan, E.
    Li, X.
    Lau, C.
    Anand, S.
    VALUE IN HEALTH, 2016, 19 (07) : A866 - A867
  • [36] Edoxaban versus Warfarin in patients with atrial fibrillation
    Meras Colunga, P.
    REVISTA CLINICA ESPANOLA, 2014, 214 (06): : 346 - 346
  • [37] Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Left Ventricular Hypertrophy Insights From the ARISTOTLE Trial
    Al-Khatib, Sana M.
    Mulder, Hillary
    Wojdyla, Daniel
    Lopes, Renato D.
    Wallentin, Lars
    Alexander, John H.
    Hijazi, Ziad
    Goto, Shinya
    Granger, Christopher B.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2021, 14 (03): : 359 - 361
  • [38] CKD Progression in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation Treatead with Apixaban Versus Warfarin
    Wetmore, James B.
    Yan, Heng
    Herzog, Charles A.
    Weinhandl, Eric
    Reyes, Jorge L.
    Roetker, Nicholas S.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 78 (02) : 180 - 189
  • [39] Safety and Efficacy of Uninterrupted Apixaban Therapy Versus Warfarin During Atrial Fibrillation Ablation
    Shah, Ruchit R.
    Pillai, Ajay
    Schafer, Pascha
    Meggo, David
    Mcelderry, Tom
    Plumb, Vance
    Yamada, Takumi
    Kumar, Vineet
    Doppalapudi, Harish
    Gunter, Alicia
    Pentecost, Emily
    Maddox, William
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2017, 28 (05) : 594 - 594
  • [40] APIXABAN COMPARED WITH WARFARIN IN PATIENTS WITH DIABETES AND NONVALVULAR ATRIAL FIBRILLATION IN THE ARISTOTLE TRIAL
    Ezekowitz, Justin A.
    Lewis, Basil
    Lopes, Renato
    Wojdyla, Daniel
    McMurray, John
    Hanna, Michael
    Atar, Dan
    Bahit, Maria
    Keltai, Matyas
    Lopez-Sendon, Jose
    Pais, Prem
    Ruzyllo, Witold
    Wallentin, Lars
    Alexander, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A372 - A372
12345